Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon: Number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = exons 3 to 7, 8i_9 = border intron 8/exon 9.
DNA change (cDNA): Description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup.
RNA change: Description of variant at RNA level (following HGVS recommendations).
- r.123c>u
- r.? = unknown
- r.(?) = RNA not analysed but probably transcribed copy of DNA variant
- r.spl? = RNA not analysed but variant probably affects splicing
- r.(spl?) = RNA not analysed but variant may affect splicing
- r.0? = change expected to abolish transcription
Protein: Description of variant at protein level (following HGVS recommendations).
- p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
- p.Arg345Pro = change derived from RNA analysis
- p.? = unknown effect
- p.0? = probably no protein produced
Variant/VariO/DNA: VariO of DNA
Variant/VariO/protein: VariO of protein
Allele: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
DNA change (genomic) (hg19): Description of variant at DNA level, based on the genomic DNA reference sequence (following HGVS recommendations).
- g.12345678C>T
- g.12345678_12345890del
- g.12345678_12345890dup
Reference: Reference to publication describing the variant, including links to OMIM (when available), PubMed or or other source, e.g. "den Dunnen ASHG2003 P2346".
DB-ID: Database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro.
Frequency: Frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested).
Effect
|
Exon
|
DNA change (cDNA)
|
RNA change
|
Protein
|
Variant/VariO/DNA
|
Variant/VariO/protein
|
DNA change (genomic) (hg19)
|
Reference
|
DB-ID
|
Frequency
|
Owner
|
./. |
1 |
c.4C>T |
r.(?) |
p.(Arg2Cys) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77566090C>T |
Creegan, pers comm;Xin et al 2010 Neurology 74:565-71;Elleder, pers comm |
CLN5_000001 |
- |
Y Yang |
./. |
1 |
c.61C>T |
r.(?) |
p.(Pro21Ser) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77566147C>T |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000033 |
- |
Y Yang |
./. |
1 |
c.72A>G |
r.(=) |
p.(=) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
- |
g.77566158A>G |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000002 |
- |
Y Yang |
./. |
1 |
c.223T>C |
r.(?) |
p.(Trp75Arg) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77566309T>C |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000034 |
- |
Y Yang |
./. |
1 |
c.225G>A |
r.(?) |
p.(Trp75*) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0015 protein truncation |
g.77566311G>A |
Savukoski et al. 1998 Nature Genetics 19:286-288;Holmberg et al. 2000 Neurology 55:579-581;Xin et al 2010 Neurology 74:565-71 |
CLN5_000003 |
- |
Y Yang |
./. |
1 |
c.234C>G |
r.(=) |
p.(=) |
VariO:0136 DNA substitution; VariO:0316 transversion |
- |
g.77566320C>G |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000004 |
- |
Y Yang |
./. |
1 |
c.291dup |
r.(?) |
p.(Ser98Leufs*13) |
VariO:0142 DNA insertion |
VariO:0023 amphigoric amino acid indel |
g.77566377dup |
Cismondi et al. 2008. Human Genetics 123: 537-555 (554) |
CLN5_000005 |
- |
Y Yang |
./. |
1i |
c.320+8C>T |
r.(=) |
p.(=) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
- |
g.77566414C>T |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000006 |
- |
Y Yang |
./. |
1i |
c.320+18C>T |
r.(=) |
p.(=) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
- |
g.77566424C>T |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000007 |
- |
Y Yang |
./. |
2 |
c.335G>A |
r.(?) |
p.(Arg112His) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0021 amino acid substitution |
g.77569212G>A |
Pineda-Trujillo et al. 2005 Neurology 64:740-742;Cregeen, pers comm |
CLN5_000008 |
- |
Y Yang |
./. |
2 |
c.335G>C |
r.(?) |
p.(Arg112Pro) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0021 amino acid substitution |
g.77569212G>C |
Bessa et al. 2006 Mol Genet Mab 89:245-253 |
CLN5_000009 |
- |
Y Yang |
./. |
2 |
c.377G>A |
r.(?) |
p.(Cys126Tyr) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0021 amino acid substitution |
g.77569254G>A |
Sleat et al. 2009. Mol Cell Pteomics 8:1708-18;Xin et al 2010 Neurology 74:565-71 |
CLN5_000010 |
- |
Y Yang |
./. |
2 |
c.433C>T |
r.(?) |
p.(Arg145*) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0015 protein truncation |
g.77569310C>T |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000035 |
- |
Y Yang |
./. |
3 |
c.524T>A |
r.(?) |
p.(Leu175*) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0015 protein truncation |
g.77570074T>A |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000036 |
- |
Y Yang |
./. |
3 |
c.527_528insA |
r.(?) |
p.(Gly177Trpfs*10) |
VariO:0142 DNA insertion |
VariO:0023 amphigoric amino acid indel |
g.77570077_77570078insA |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000011 |
- |
Y Yang |
./. |
3 |
c.528T>G |
r.(=) |
p.(=) |
VariO:0136 DNA substitution; VariO:0316 transversion |
- |
g.77570078T>G |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000012 |
- |
Y Yang |
./. |
3 |
c.565C>T |
r.(?) |
p.(Gln189*) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0015 protein truncation |
g.77570115C>T |
Bessa et al. 2006 Mol Genet Mab 89:245-253 |
CLN5_000013 |
- |
Y Yang |
./. |
3 |
c.575A>G |
r.(?) |
p.(Asn192Ser) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0021 amino acid substitution |
g.77570125A>G |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000014 |
- |
Y Yang |
./. |
3 |
c.593T>C |
r.(?) |
p.(Leu198Pro) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77570143T>C |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000037 |
- |
Y Yang |
./. |
3 |
c.613C>T |
r.(?) |
p.(Pro205Ser) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77570163C>T |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000038 |
- |
Y Yang |
./. |
3 |
c.613C>T |
r.(?) |
p.(Pro205Ser) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77570163C>T |
Al-Kowari MK1, Hassan S, El-Said MF, Ben-Omran T, Hedin L, Mole SE, Badii R.(2011) |
CLN5_000038 |
- |
Y Yang |
./. |
3 |
c.619T>C |
r.(?) |
p.(Trp207Arg) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77570169T>C |
Cregeen, pers comm |
CLN5_000015 |
- |
Y Yang |
./. |
3 |
c.619T>C |
r.(?) |
p.(Trp207Arg) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0314 pyrimidine transition |
VariO:0021 amino acid substitution |
g.77570169T>C |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000015 |
- |
Y Yang |
./. |
3 |
c.620G>C |
r.(?) |
p.(Trp207Ser) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0021 amino acid substitution |
g.77570170G>C |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000016 |
- |
Y Yang |
./. |
3 |
c.671G>A |
r.(?) |
p.(Trp224*) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0015 protein truncation |
g.77570221G>A |
Cregeen, pers comm;Xin et al 2010 Neurology 74:565-71 |
CLN5_000017 |
- |
Y Yang |
./. |
4 |
c.713_900del |
r.(?) |
p.(Gly238Aspfs*21) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574593_77574780del |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000041 |
- |
Y Yang |
./. |
4 |
c.726C>A |
r.(?) |
p.(Asn242Lys) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0021 amino acid substitution |
g.77574606C>A |
Cregeen, pers comm |
CLN5_000018 |
- |
Y Yang |
./. |
4 |
c.726C>A |
r.(?) |
p.(Asn242Lys) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0021 amino acid substitution |
g.77574606C>A |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000018 |
- |
Y Yang |
./. |
4 |
c.772T>G |
r.(?) |
p.(Tyr258Asp) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0021 amino acid substitution |
g.77574652T>G |
Cannelli et al. 2007 Neuropediat 38:146-49 |
CLN5_000019 |
- |
Y Yang |
./. |
4 |
c.835G>A |
r.(?) |
p.(Asp279Asn) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0021 amino acid substitution |
g.77574715G>A |
Savukoski et al. 1998 Nature Genetics 19:286-288;Holmberg et al. 2000 Neurology 55:579-581;Bessa et al. 2006 Mol Genet Mab 89:245-253 |
CLN5_000020 |
- |
Y Yang |
./. |
4 |
c.919delA |
r.(?) |
p.(Arg307Glufs*29) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574799delA |
Xin et al 2010 Neurology 74:565-71;Amr and Abdel-Hamid pers comm |
CLN5_000021 |
- |
Y Yang |
./. |
4i |
c.955_970del |
r.(?) |
p.(Gly319Phefs*12) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574835_77574850del |
Kousi M1, Lehesjoki AE, Mole SE.(2012) |
CLN5_000039 |
- |
Y Yang |
./. |
4 |
c.955_970del16 |
r.(?) |
p.(Gly319Phefs*12) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574835_77574850del16 |
Cregeen, pers comm |
CLN5_000040 |
- |
Y Yang |
./. |
4 |
c.1026C>A |
r.(?) |
p.(Tyr342*) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0015 protein truncation |
g.77574906C>A |
Kousi et al 2009. Brain 132:810-9 |
CLN5_000022 |
- |
Y Yang |
./. |
4 |
c.1054G>T |
r.(?) |
p.(Glu352*) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0015 protein truncation |
g.77574934G>T |
Moore et al 2008 Clin Genet. 74:213-22 |
CLN5_000023 |
- |
Y Yang |
./. |
4 |
c.1071_1072delCT |
r.(?) |
p.(Leu358Alafs*4) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574951_77574952delCT |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000024 |
- |
Y Yang |
./. |
4 |
c.1072_1073delTT |
r.(?) |
p.(Leu358Alafs*4) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574952_77574953delTT |
Lebrun et al. 2009 Hum Mutat in press |
CLN5_000025 |
- |
Y Yang |
./. |
4 |
c.1083delT |
r.(?) |
p.(Phe361Leufs*4) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574963delT |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000026 |
- |
Y Yang |
./. |
4 |
c.1103A>G |
r.(?) |
p.(Lys368Arg) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0021 amino acid substitution |
g.77574983A>G |
Savukoski et al. 1998 Nature Genetics 19:286-288;Xin et al 2010 Neurology 74:565-71 |
CLN5_000027 |
- |
Y Yang |
./. |
4 |
c.1103_1106delAACA |
r.(?) |
p.(Lys368Serfs*15) |
VariO:0141 DNA deletion |
VariO:0023 amphigoric amino acid indel |
g.77574983_77574986delAACA |
Xin et al 2010 Neurology 74:565-71;Kohan et al. 2008. Human Genetics 123: 537-555 (552) |
CLN5_000028 |
- |
Y Yang |
./. |
4 |
c.1121A>G |
r.(?) |
p.(Tyr374Cys) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
VariO:0021 amino acid substitution |
g.77575001A>G |
Sleat et al. 2009. Mol Cell Pteomics 8:1708-18;Xin et al 2010 Neurology 74:565-71 |
CLN5_000029 |
- |
Y Yang |
./. |
4 |
c.1137G>T |
r.(?) |
p.(Trp379Cys) |
VariO:0136 DNA substitution; VariO:0316 transversion |
VariO:0021 amino acid substitution |
g.77575017G>T |
Lebrun et al. 2009 Hum Mutat 30:E651-61 |
CLN5_000031 |
- |
Y Yang |
./. |
4 |
c.1175_1176delAT |
r.(?) |
p.(Tyr392*) |
VariO:0141 DNA deletion |
VariO:0015 protein truncation |
g.77575055_77575056delAT |
Savukoski et al. 1998 Nature Genetics 19:286-288;Holmberg et al. 2000 Neurology 55:579-581 |
CLN5_000032 |
- |
Y Yang |
./. |
4 |
c.1175_1176delAT |
r.(?) |
p.(Tyr392*) |
- |
- |
g.77575055_77575056delAT |
Uusi-Rauva K et aL. (2017) |
CLN5_000032 |
- |
XY Liu |
./. |
3UTR |
c.*33A>G |
r.(=) |
p.(=) |
VariO:0136 DNA substitution; VariO:0313 transition; VariO:0315 purine transition |
- |
g.77575137A>G |
Xin et al 2010 Neurology 74:565-71 |
CLN5_000030 |
- |
Y Yang |